Work

TREM-1 upregulation as a potential predictive immune biomarker of pathologic complete response (pCR) in patients (pts) with triple-negative breast cancer (TNBC) receiving neoadjuvant therapy (NAT).

Year: 2025

Type: article

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.e12632

Authors: Albert Jang, Nickolas Stabellini, Nerea Lopetegui-Lia, Mona Patel, Megan Lynn Kruse, Pat Rayman, Paul Pavicic, Alberto J. Montero, C. Marcela Diaz-Montero

Institutions: University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Case Western Reserve University, University Hospitals Cleveland Medical Center, Cleveland Clinic, University Hospitals of Cleveland

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410815337

FWCI:

Cites:

Cited by:

Related to: 10